Jacobs Levy Equity Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-91,118
| Closed | -$446K | – | 1064 |
|
|
2024
Q2 | $446K | Buy |
91,118
+56,411
| +163% | +$276K | ﹤0.01% | 851 |
|
|
2024
Q1 | $201K | Buy |
34,707
+17,557
| +102% | +$102K | ﹤0.01% | 891 |
|
|
2023
Q4 | $112K | Sell |
17,150
-45,425
| -73% | -$298K | ﹤0.01% | 949 |
|
|
2023
Q3 | $302K | Buy |
+62,575
| New | +$302K | ﹤0.01% | 875 |
|
|
2019
Q2 | – | Sell |
-8,258
| Closed | -$221K | – | 1042 |
|
|
2019
Q1 | $221K | Buy |
8,258
+4,536
| +122% | +$121K | ﹤0.01% | 880 |
|
|
2018
Q4 | $106K | Buy |
3,722
+1,363
| +58% | +$38.8K | ﹤0.01% | 939 |
|
|
2018
Q3 | $181K | Sell |
2,359
-725
| -24% | -$55.6K | ﹤0.01% | 936 |
|
|
2018
Q2 | $321K | Buy |
3,084
+319
| +12% | +$33.2K | 0.01% | 877 |
|
|
2018
Q1 | $350K | Sell |
2,765
-609
| -18% | -$77.1K | 0.01% | 838 |
|
|
2017
Q4 | $219K | Sell |
3,374
-75
| -2% | -$4.87K | ﹤0.01% | 890 |
|
|
2017
Q3 | $204K | Buy |
+3,449
| New | +$204K | ﹤0.01% | 858 |
|